1. Home
  2. JL vs AYTU Comparison

JL vs AYTU Comparison

Compare JL & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JL
  • AYTU
  • Stock Information
  • Founded
  • JL 1985
  • AYTU N/A
  • Country
  • JL Hong Kong
  • AYTU United States
  • Employees
  • JL N/A
  • AYTU N/A
  • Industry
  • JL
  • AYTU Biotechnology: Pharmaceutical Preparations
  • Sector
  • JL
  • AYTU Health Care
  • Exchange
  • JL NYSE
  • AYTU Nasdaq
  • Market Cap
  • JL 13.7M
  • AYTU 15.0M
  • IPO Year
  • JL 2024
  • AYTU N/A
  • Fundamental
  • Price
  • JL $0.39
  • AYTU $2.24
  • Analyst Decision
  • JL
  • AYTU
  • Analyst Count
  • JL 0
  • AYTU 0
  • Target Price
  • JL N/A
  • AYTU N/A
  • AVG Volume (30 Days)
  • JL 303.0K
  • AYTU 32.2K
  • Earning Date
  • JL 11-02-2024
  • AYTU 11-12-2024
  • Dividend Yield
  • JL N/A
  • AYTU N/A
  • EPS Growth
  • JL N/A
  • AYTU N/A
  • EPS
  • JL 0.03
  • AYTU N/A
  • Revenue
  • JL $28,378,669.00
  • AYTU $81,002,000.00
  • Revenue This Year
  • JL N/A
  • AYTU N/A
  • Revenue Next Year
  • JL N/A
  • AYTU N/A
  • P/E Ratio
  • JL $15.04
  • AYTU N/A
  • Revenue Growth
  • JL N/A
  • AYTU N/A
  • 52 Week Low
  • JL $0.30
  • AYTU $2.11
  • 52 Week High
  • JL $29.95
  • AYTU $3.50
  • Technical
  • Relative Strength Index (RSI)
  • JL 49.58
  • AYTU 40.89
  • Support Level
  • JL $0.36
  • AYTU $2.11
  • Resistance Level
  • JL $0.44
  • AYTU $2.44
  • Average True Range (ATR)
  • JL 0.03
  • AYTU 0.14
  • MACD
  • JL -0.00
  • AYTU -0.02
  • Stochastic Oscillator
  • JL 40.82
  • AYTU 17.57

About JL J-LONG GROUP LIMITED

J-Long Group Ltd is an established distributor in Hong Kong of reflective and non-reflective garment trims including, among others, heat transfers, fabrics, woven labels and tapes, sewing badges, piping, zipper pullers and drawcords. It also offers a wide range of apparel solution services to cater to its customers' needs for reflective and non-reflective garment trims, ranging from market trend analysis, product design and development and production to quality control.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimentary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. AR101/enzastaurin has received Orphan Drug designation from the FDA. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which it generates maximum revenue from the Rx segment.

Share on Social Networks: